Wednesday, June 21, 2023
Sensome and Asahi Intecc have recently announced a collaboration to develop the next generation of Clotild® Smart Guidewire for the treatment of acute ischaemic stroke.
The collaboration between Sensome and Asahi Intecc represents an exciting union of groundbreaking sensor technology. By combining these strengths, the two companies are pushing the boundaries of medical technology and aiming to make a profound impact on patient outcomes globally.
Together this collaboration seeks to revolutionise the medical field and bring forth innovative solutions to improve patient care. By joining forces, Sensome and Asahi are poised to make significant strides in the development of cutting-edge smart guidewires that cater to the evolving needs of the medical industry.
The Clotild® Smart Guidewire represents a significant advancement in the field, offering a promising solution to address the existing challenges in clot removal procedures and enables physicians to make more informed decisions during the procedure, potentially leading to improved success rates and better patient outcomes.
Acute ischaemic stroke is the leading cause of acquired long-term disability, and mechanical thrombectomy is a procedure used to treat this condition. The procedure makes use of a thrombectomy device that is passed over a wire from either the wrist or the groin to reach the site of the blockage.
